Publications by authors named "Boris Redko"

Claim this Profile
A
Allosteric inhibitors targeting the calmodulin-PIP2 interface of SK4 K channels for atrial fibrillation treatment.
Shira Burg, Shir Shapiro, Asher Peretz, Elvira Haimov, Boris Redko

Proc Natl Acad Sci U S A· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective Stepwise Arylation of Unprotected Peptides by Pt Complexes.
Xiaoxi Lin, Elvira Haimov, Boris Redko, Arkadi Vigalok

Angew Chem Int Ed Engl· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural basis for long-chain isoprenoid synthesis by -prenyltransferases.
Moshe Giladi, Michal Lisnyansky Bar-El, Pavla Vaňková, Alisa Ferofontov, Emelia Melvin, Boris Redko

Sci Adv· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-Cancer Effects of Cyclic Peptide ALOS4 in a Human Melanoma Mouse Model.
Bar Levi, Shiri Yacobovich, Michael Kirby, Maria Becker, Oryan Agranyoni, Boris Redko

Int J Mol Sci· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-Assembled Peptide Nano-Superstructure towards Enzyme Mimicking Hydrolysis.
Yu Chen, Yuqin Yang, Asuka A Orr, Pandeeswar Makam, Boris Redko

Angew Chem Int Ed Engl· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma.
Boris Redko, Helena Tuchinsky, Tamar Segal, Dror Tobi, Galia Luboshits

Oncotarget· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel synthetic cyclic integrin αvβ3 binding peptide ALOS4: Antitumor activity in mouse melanoma models.
Shiri Yacobovich, Lena Tuchinsky, Michael Kirby, Tetiana Kardash, Oryan Agranyoni, Boris Redko

Oncotarget· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiproliferative Effect of Novel Aminoacridine-based Compounds.
Anna Munder, Yoni Moskovitz, Boris Redko, Ariel Rachel Levy, Sharon Ruthstein

Med Chem· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biolabile peptidyl delivery systems toward sequential drug release.
Elena Ragozin, Boris Redko, Elena Tuchinsky, Alex Rozovsky, Amnon Albeck

Biopolymers· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, drug release, and biological evaluation of new anticancer drug-bioconjugates containing somatostatin backbone cyclic analog as a targeting moiety.
Boris Redko, Elena Ragozin, Bazylevich Andreii, Tuchinsky Helena, Albeck Amnon

Biopolymers· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Switch off/switch on" regulation of drug cytotoxicity by conjugation to a cell targeting peptide.
Yossi Gilad, Michael A Firer, Alex Rozovsky, Elena Ragozin, Boris Redko

Eur J Med Chem· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis